Ethical, Legal, and Social Issues Substudy in Relation to the GTEx Project (ELSI)

March 29, 2021 updated by: Laura Siminoff, Temple University

Ethical, Legal, and Social Issues Substudy in Relation to the Genotype-Tissue Expression Project

The Ethical, Legal and Social Issues Substudy in relation to the Genotype Tissue Expression Project (GTEx) aims to describe tissue requesters' approach to discussions about donation to GTEx and to assess the determinants of families' and patients' willingness to donate to GTEx. It also explores ethical issues such as privacy, risks, and release of incidental findings and recommend best practices for conducting authorizations and training requesters.

Study Overview

Status

Completed

Detailed Description

The Genotype Tissue Expression Project (GTEx) is a partnership between multiple NIH agencies and funded by the Common Fund. Families who agreed to donation of organs and tissues for transplantation were asked to authorize the collection of additional tissues for GTEx by participating Organ Procurement Organizations (OPO). Donated tissues are placed in a National Cancer Institute biobank, and the donor's genome and medical record information analyzed and released to researchers through NIH's database of Genotypes and Phenotypes (dbGaP). The tissues and information will be kept in the biobank indefinitely and cell lines may be developed from the donated skin and blood.

An ethical, legal and social issues (ELSI) sub-study examines the issues surrounding risks to privacy and breach of confidentiality to family decision makers (FDM) as well as FDM perspectives on the return of findings to donor families. The ELSI sub-study assessed the authorization process and make suggestions for its improvement. Semi-structured interviews were completed with families who decided to donate to GTEx as well as those who refused to donate to the project. Tissue requesters (TR) who make the GTEx approaches for participating OPOs, were also asked to complete an online survey for each approach they completed for GTEx.

The study builds on this research team's extensive work in organ and tissue donation and the work currently being conducting during the ELSI pilot of the GTEx project. Specifically, the investigators propose to examine the impact of stress and complex information on donor families' decision-making to inform the consent process; understand how variations in requesters, consent approaches, and the characteristics of family decision makers affect understanding, recall of and willingness to donate tissues for research; consider the ethical and legal issues of the request and consent process; and, test a novel intervention designed to train tissue requesters to employ effective communication techniques when making requests for tissue. The overall goal is to develop a set of recommendations that will maximize the likelihood that family decision makers (FDM) make informed donation decisions under stressful circumstances. The specific aims of the ELSI GTEx study are:

This study will build on this research team's extensive work in organ and tissue donation and the work they are currently conducting during the ELSI pilot of the GTEx project. Specifically, the investigators propose to examine the impact of stress and complex information on the decision making of donor families to inform the consent process, understand how variations in requesters, consent approaches, and the characteristics of family decision makers affect understanding and recall of and willingness to donate tissues for research, consider the ethical and legal issues of the request and consent process, and test an intervention to train tissue requesters to employ effective communication techniques when making requests for tissue. The overall goal is to develop a set of recommendations that will maximize the likelihood that family decision makers (FDM) make informed donation decisions under stressful circumstances. The specific aims of the ELSI GTEx study are:

  1. Identify elements of nonverbal and relational communication impacting FDM knowledge, recall and GTEx decision making. Using the methods and procedures of the pilot study, the investigators will conduct an observational study of the GTEx request process to understand the communication-related variables impacting FDM knowledge, recall and decision making. In addition, a subsample of audiotapes will be obtained from tissue-only donors whose consent conversations are conducted by telephone and are audiotaped. This will provide information about the important nonverbal and relational elements of communication on the outcome variables.

    H1a. Sociodemographic characteristics of FDM will impact the major outcomes of interest to this study (recall, comprehension and consent). Specifically, FDM who have more education, are white, female and younger will be more likely to donate, have better recall and knowledge.

    H1b. Relational elements of communication, such as confirmational messages (e.g., messages that expressed validation or acceptance) or persuasive tactics such as credibility, altruism, or esteem, and engaging in a lengthier conversation will be associated with a greater likelihood to donate have better recall and knowledge.

    H1c. Tissue requesters' and FDMs' comfort speaking about GTEx, the proclivity of FDMs to ask question and engage more proactively in the conversation will be associated with a greater likelihood to donate have better recall and knowledge.

  2. Conduct a study, using a quasi-experimental design, to understand the impact of the stressful environment in which the requests occur. This study will assist the ELSI team to obtain an evidence base that will allow us to disentangle the effects of stress from the complexity of the information about the purpose of the donation and guide recommendations for a final consent process.
  3. Adapt and test a communication intervention targeting tissue requesters' (TR) use of effective, ethically acceptable techniques that maximize the likelihood of consent.

H3a. Post intervention, TRs will exhibit more relational communication with FDMs during requests. H3b. Post intervention, TRs will spend more time attending to the emotional needs of FDMs.

H3c. Post intervention, TRs will spend more time discussing information identified as important to informed decision making for tissue donation.

H3d. Post intervention, there will be overall higher consent rates for donation to the research.

Study Type

Interventional

Enrollment (Actual)

512

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Virginia
      • Richmond, Virginia, United States, 23219
        • Virginia Commonwealth University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

Participants must either be a:

  1. family decision maker approached to donate their loved one's tissues to the GTEx project or
  2. a staff person at an OPO that approaches family decision makers for the GTEx project.

Exclusion Criteria:

1. Persons who neither approached for GTEx or were approached are excluded from participation.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Intervention Group
Tissue requesters from participating OPOs are randomly assigned to complete additional informed consent training through an interactive online training website.
Additional training website can be found at gtextraing.org
Experimental: Control Group
The control group of tissue requesters receive the standard training offered by their OPO and GTEx partners.
Standard training given by OPOs and GTEx staff

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Number of family members who chose to donate to GTEx
Time Frame: Up to 8 months after donation request
Number of family decision makers who choose to donate to GTEx
Up to 8 months after donation request

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Knowledge and Comprehension of Elements of Consent
Time Frame: Up to 8 months after donation request
Knowledge and comprehension were assessed by participant answers to questionnaire.
Up to 8 months after donation request

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Laura Siminoff, PhD, Temple University
  • Principal Investigator: Heather Traino, PhD, Temple University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

March 1, 2013

Primary Completion (Actual)

August 1, 2016

Study Completion (Actual)

December 1, 2017

Study Registration Dates

First Submitted

December 17, 2015

First Submitted That Met QC Criteria

August 29, 2016

First Posted (Estimate)

September 2, 2016

Study Record Updates

Last Update Posted (Actual)

March 30, 2021

Last Update Submitted That Met QC Criteria

March 29, 2021

Last Verified

March 1, 2021

More Information

Terms related to this study

Other Study ID Numbers

  • 10XS170

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Standard Training

Clinical Trials on Training Website

3
Subscribe